PTIX - Protagenic Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
14.47M
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.13
52-Week Change 3∞%
S&P500 52-Week Change 325.98%
52 Week High 33.8000
52 Week Low 31.4000
50-Day Moving Average 32.0726
200-Day Moving Average 31.7848

Share Statistics

Avg Vol (3 month) 310
Avg Vol (10 day) 3N/A
Shares Outstanding 510.26M
Float 6.1M
% Held by Insiders 129.85%
% Held by Institutions 15.00%
Shares Short (Oct 30, 2011) 437
Short Ratio (Oct 30, 2011) 49.29
Short % of Float (Oct 30, 2011) 416.44%
Short % of Shares Outstanding (Oct 30, 2011) 49.02%
Shares Short (prior month Sep 29, 2011) 439

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15464
Last Split Date 3Jul 26, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-183.25%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -1.87M
Net Income Avi to Common (ttm)-1.79M
Diluted EPS (ttm)-0.1750
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)277.39k
Total Cash Per Share (mrq)0.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.44
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-646.36k
Levered Free Cash Flow (ttm)-20.44k